Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England.
Vicki OsborneMiranda DaviesAlison EvansSaad A W ShakirPublished in: Therapeutic advances in psychopharmacology (2020)
Utilisation of quetiapine XL appeared to be in line with prescribing guidelines in terms of dose, and commonly reported events of interest were in concordance with the known safety profile. Overall, this SCEM study provided important information on the safety and utilisation of quetiapine XL in the secondary care setting in England.